Novozymes, a Danish biotech company that has a lab in Davis, has completed the acquisition of EMD/Merck Crop BioScience.
“We’re excited to bring these two innovative companies together to help farmers produce more and better food, feed, fuel and fiber while minimizing the environmental footprint,” Thomas Videbæk, executive vice president of Novozymes, said in a news release.
The $238 million deal complements Novozymes’ existing agricultural biologicals business.
“The people, products and technical expertise being brought together holds the potential to accelerate the development of new products and better meet farmers’ current and future needs for sustainable solutions,” the release said.
The combination of products will offer farmers more choice on multiple action products with complementary benefits, the company reports.
Novozymes’ biofertility products increase the supply of nutrients to crops and include nitrogen inoculants for legume crops, signaling compounds to enhance nitrogen fixation, and products that increase the availability of phosphate to crops. Novozymes’ biocontrol products control insect, disease and weed crop pests; and Novozymes’ bioyield enhancement products stimulate crop stress resistance, and generally improve crop health and productivity, according to the company.